GlassScriptPhysician profile
Thomas Corbett Appleby
NPI 1801985007
$89,002.38
in general payments reported to CMS, 2019-2025
21 companies · $6,119 in 2025
The $6,119 reported for 2025 was more than what 86% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $3,157 · 2021: $9,827 · 2022: $13K · 2023: $20K · 2024: $18K · 2025: $6,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,500 · Travel and Lodging: $2,616 · Food and Beverage: $1,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,500.00 |
| Travel and Lodging | $2,616.45 |
| Food and Beverage | $1,379.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $86,286.39 | 2019-2025 | Mars Anterior Retractor, Alif, Corbel |
| Medtronic, INC. | $468.79 | 2021-2025 | Hawkone, In.Pact Av, Abre |
| W. L. Gore & Associates, INC. | $465.89 | 2019-2025 | Gore Excluder Aaa Endoprosthesis, Gore Viabahn Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Lemaitre Vascular, INC. | $257.22 | 2022-2025 | Trivex System, Artegraft Vascular Graft, Xenosure Biologic Patch |
| Stryker Corporation | $215.88 | 2025 | Ct Thrombectomy System Kit, Clottriever Bold Catheter, Artix Mt |
| Silk Road Medical, INC. | $200.70 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Biocompatibles, INC. | $192.27 | 2019 | |
| Boston Scientific Corporation | $161.04 | 2020-2025 | Enroute Transcarotid Neuroprotection System |
| E.R. Squibb & Sons, L.L.C. | $153.32 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $92.64 | 2023 | Venclose Maven Catheter |
| Medtronic Vascular, INC. | $85.12 | 2019-2020 | |
| Smith+Nephew, INC. | $72.69 | 2022-2024 | Stravix, Grafix Pl |
| Pfizer INC. | $66.56 | 2019-2023 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $56.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $54.89 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $41.48 | 2023-2025 | Auryon Laser System 100-120 Vac |
| Kci USA, INC. | $34.44 | 2021-2022 | |
| Convatec INC. | $32.09 | 2019-2025 | |
| Cook Medical LLC | $30.24 | 2025 | Zilver Ptx |
| Medela LLC | $21.73 | 2020 | |
| Cardiva Medical, INC. | $13.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Appleby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.